Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Large ribosomal subunit protein mL37, mitochondrial (MRPL37) is a nuclear-encoded protein that is a structural component of the 39S large subunit of mitochondrial ribosomes (mitoribosomes), which function in protein synthesis within mitochondria. Mitoribosomes are distinct from prokaryotic ribosomes in their protein-to-rRNA ratio and lack of 5S rRNA, and their protein sequences often vary between species, complicating their identification based on homology. MRPL37 is associated with mitochondrial translation and, by extension, with the proper maintenance of mitochondrial function[1][4][5][7][9][11]. Disruptions in MRPL37 have been linked to mitochondrial diseases such as combined oxidative phosphorylation deficiency and thrombophilia[1]. No drugs are currently known to interact directly with MRPL37, and it is not recognized as a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Large ribosomal subunit protein mL37, mitochondrial (MRPL37).